Compare Home Depot Inc (HD) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs IDEXX Laboratories, Inc. — how do they compare? Home Depot Inc trades at $344.71 (market cap $353.46B), while IDEXX Laboratories, Inc. trades at $573.05 (market cap $46.22B). The key difference: Home Depot Inc is far larger — about 7.6× IDEXX Laboratories, Inc.'s market cap, and Home Depot Inc pays a 2.63% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| HD | IDXX | |
|---|---|---|
Market Cap | $353.46B | $46.22B |
Sector | Consumer Cyclical | Health |
52-Week High | $423.42 | $766.68 |
52-Week Low | $297.51 | $526.44 |
Enterprise Value | $415.01B | $47.12B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $350.78, down 1.36% on the day, with a bullish technical outlook supported by moving averages. The company reported mixed quarterly earnings, missing in Q3 2025 but beating in Q4 2025 and Q1 2026. Strong profitability metrics include a 33.13% gross margin and 128.38% ROE, though net margins have declined from 10.87% in 2022 to 8.41% in 2026. Recent news highlights institutional trading activity and concerns about weakening big-ticket demand amid rising mortgage rates.
The stock offers a 6% upside to the consensus price target of $371.25, with 59% of analysts rating it Buy. Key risks include housing market sensitivity and margin pressure from investments. Long-term growth drivers include Pro customer focus and digital expansion, but near-term headwinds from economic conditions warrant caution.
IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.
Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
